July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at
All Pricing Transparency Items
June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their
June 20, 2019 Our legal team at Steptoe & Johnson tracks healthcare reform bills in the 116th Congress. These documents are updated as of June 14. Federal Healthcare Reform Tracker.
June 20, 2019 In case you missed it, we reported live from The Council’s Employee Benefits Leadership Forum (EBLF). Close to 600 industry leaders convened in Colorado Springs, Colo., to
Surprise Medical Billing Broad bipartisan support from the Trump administration as well as Congress has created momentum around surprise medical billing. Earlier this week, the House Energy and Commerce Committee
April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can
March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on
The State of Montana’s health plan was hemorrhaging money with a little over 60% of the costs coming from hospital care and pharmacy benefits. Enter Marilynn Bartlett, the Special Projects
March 14, 2018 HHS Secretary Alex Azar and FDA Commissioner Scott Gottlieb want pharmacy benefit managers (PBMs) and health plans to pass on more savings to consumers when they pick
January 24, 2018 Our legal team at Steptoe & Johnson has updated its Drug Price Transparency Tracker as of January 24. Click here for the PDF.